Why the study?
Does twice daily acebutolol reduce diastolic blood pressure in patients with mild to severe hypertension?
Does twice daily acebutolol reduce diastolic blood pressure in patients with mild to severe hypertension?
Twice daily acebutolol significantly reduces diastolic blood pressure in patients with mild to severe hypertension over 12 weeks, though side effects led to withdrawal in approximately 6% of patients.
Answers are grounded in this paper and cite their sources.
Twice-daily acebutolol was associated with DBP reduction in this cohort; leaves open need for randomized confirmation before any practice change.
An open multicentre study was carried out under uncontrolled conditions in general practice to investigate the efficacy and acceptability of twice daily acebutolol in patients with mild to severe hypertension. Data from 1007 patients were analyzed. Most (901) had been treated previously with other hypertensive agents before starting on acebutolol. Oral dosages of acebutolol ranged from 200 mg to 1200 mg/day, according to individual requirements, and 331 patients received concomitant therapy, usually with a diuretic, either from the start of therapy or after 4 to 8 weeks. A significant reduction (p less than 0.001) was observed in mean diastolic blood pressure over the 12-week assessment period, and response increased with treatment duration. There were 280 reports of side-effects and 63 patients were withdrawn from the study for this reason.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: